These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7865753)

  • 1. Intracranial metyrapone stimulates CRF-ACTH axis in the teleost, Clarias batrachus: possible role of neurosteroids.
    Jain MR; Khan FA; Krishna NS; Subhedar N
    Neuroreport; 1994 Oct; 5(16):2093-6. PubMed ID: 7865753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition.
    Van Vugt DA; Piercy J; Farley AE; Reid RL; Rivest S
    Endocrinology; 1997 Jun; 138(6):2249-58. PubMed ID: 9165008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.
    Aguilera G; Wynn PC; Harwood JP; Hauger RL; Millan MA; Grewe C; Catt KJ
    Neuroendocrinology; 1986; 43(1):79-88. PubMed ID: 3012395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M; Moreira AC
    Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat.
    Rivier C; Rivier J; Lee S
    Brain Res; 1996 May; 721(1-2):83-90. PubMed ID: 8793087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished cortisol levels in subordinate female marmosets are associated with altered central drive to the hypothalamic-pituitary-adrenal axis.
    Saltzman W; Hogan BK; Abbott DH
    Biol Psychiatry; 2006 Oct; 60(8):843-9. PubMed ID: 16499881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status.
    Ur E; Dinan TG; O'Keane V; Clare AW; McLoughlin L; Rees LH; Turner TH; Grossman A; Besser GM
    Neuroendocrinology; 1992 Oct; 56(4):533-8. PubMed ID: 1335555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
    Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
    Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.
    Holmes SJ; Florkowski CM; Evans MJ; Ellis MJ; Livesey JH; Donald RA; Espiner EA
    J Endocrinol Invest; 1993 Nov; 16(10):787-92. PubMed ID: 8144852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of nucleus preopticus neurosecretory cells to ovarian pressure in the teleost, Clarias batrachus (Linn.).
    Subhedar N; Rama Krishna NS; Deshmukh MK
    Gen Comp Endocrinol; 1987 Dec; 68(3):357-68. PubMed ID: 3436513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cocaine and corticotropin-releasing factor on pulsatile ACTH and cortisol release in ovariectomized rhesus monkeys.
    Sarnyai Z; Mello NK; Mendelson JH; Nguyen PH; Erös-Sarnyai M
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2745-51. PubMed ID: 7673418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin reduces metyrapone-induced ACTH secretion in human subjects.
    Chiodera P; Coiro V
    Brain Res; 1987 Sep; 420(1):178-81. PubMed ID: 2823973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
    Hirotani C; Oki Y; Ukai K; Okuno T; Kurasaki S; Ohyama T; Doi N; Sasaki K; Ase K
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):54-60. PubMed ID: 15645295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interleukin 1 beta: corticotropin releasing factor and ACTH release and gene expression in the male rat: in vivo and in vitro studies.
    Mélik Parsadaniantz S; Levin N; Lenoir V; Roberts JL; Kerdelhué B
    J Neurosci Res; 1994 Apr; 37(6):675-82. PubMed ID: 7519272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone.
    Lisansky J; Peake GT; Strassman RJ; Qualls C; Meikle AW; Risch SC; Fava GA; Zownir-Brazis M; Hochla P; Britton D
    Arch Gen Psychiatry; 1989 Jul; 46(7):641-9. PubMed ID: 2544155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.